Secukinumab: A positive outcome in a patient with severe psoriasis and HBV-HCV co-infection

Dermatol Ther. 2018 Jul;31(4):e12601. doi: 10.1111/dth.12601. Epub 2018 Apr 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Coinfection*
  • Dermatologic Agents / therapeutic use*
  • Hepatitis B / complications*
  • Hepatitis B / diagnosis
  • Hepatitis C / complications*
  • Hepatitis C / diagnosis
  • Humans
  • Male
  • Psoriasis / complications
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Severity of Illness Index
  • Skin / drug effects*
  • Skin / pathology
  • Treatment Outcome
  • Viral Load

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • secukinumab